Skip to main content
OpenTrials

Clinical trial condition

Abdominal Neoplasms

Explore clinical trials studying Abdominal Neoplasms. Study availability and eligibility vary by location and protocol.

175 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Abdominal Neoplasms trial results

Completed

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

NCT00074867

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Santa Monica, California, United States
  • Pfizer Investigational Site Baltimore, Maryland, United States
  • Pfizer Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

NCT00103545

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
Locations
  • Clinic for Gynecology and Gyn. Oncology, Humboldt University Berlin, Germany
  • University Clinic Carl Gustav Carus, Gynecological hospital Dresden, Germany
  • Gynecologic Hospital Düsseldorf, Germany
  • University Gynecologic Hospital Essen, Germany
View Trial Details
Active, Not Recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

NCT04498117

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Health Clinical Research Center Concord, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
View all 148 locations
View Trial Details
Active, Not Recruiting

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

NCT02758951

Conditions
Abdominal Neoplasms, Body Temperature Changes, Colonic Diseases, +28 more
Locations
  • Ziekenhuis Oost-Limburg Genk, Flanders, Belgium
  • Amsterdam University Medical Centre, Location VUMC Amsterdam, Netherlands
  • Netherlands Cancer Institute Amsterdam, Netherlands
  • Catharina Hospital Eindhoven, Netherlands
View Trial Details
Active, Not Recruiting

Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors

NCT03252938

Conditions
Abdominal Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +12 more
Locations
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • Kliniken der Stadt Köln gGmbH, Studienzentrum der Lungenklinik, Krankenhaus Merheim Cologne, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Agaplesion Markus Krankenhaus Frankfurter Diakonie Kliniken gGmbH Frankfurt, Germany
View Trial Details

Related conditions